PRODUCTS
SERVICES
Investment objective of the scheme is to provide long term capital appreciation by investing in equity & equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes objectives will be achieved.
2.34
5 yrs 9 m
1%
814.95 Crs
1% on or before 30D, Nil after 30D
Large Growth
8.39
SIP 100 & Lumpsum 1000
NA
Dhaval Shah
Investors understand that their principal will be at very high risk